
SLENYTO® is indicated for the treatment of insomnia in children and adolescents aged 2-18 with Autism Spectrum Disorder (ASD) and/or neurogenetic disorders with aberrant diurnal melatonin secretion and /or nocturnal awakenings, where sleep hygiene measures have been insufficient.
SLENYTO® is a 3mm diameter film coated mini-tablet that contains the active ingredient, melatonin, a hormone produced naturally by the body.
SLENYTO® is available in two dosage forms – 1 mg prolonged-release melatonin tablets and 5 mg prolonged-release melatonin tablets
SLENYTO® is a prescription-only medicine and should always be used exactly as advised by the doctor or pharmacist.

CIRCADIN® is approved for the short-term treatment of primary insomnia characterized by poor quality of sleep, in patients aged 55 years and older.
CIRCADIN® is a 2mg prolonged-release melatonin tablets
The active substance of Circadin, melatonin, belongs to a natural group of hormones produced by the body.
CIRCADIN® is a prescription-only medicine and should always be taken exactly as advised by the physician or pharmacist.